- Accelerating AI adoption for productivity and high-stakes decision-making.
- Strategic collaborations and acquisitions are accelerating enterprise AI adoption, with AI acting as a major company tailwind.
- Companies including BMS, GSK, and Sanofi are adopting AI solutions for workflows, while C3.ai expands its role in manufacturing.
C3.ai is expanding its AI solutions through partnerships with Microsoft and securing major wins with Bristol-Myers Squibb and USC Shoah Foundation.
7 reports, 3 independent
Updated Aug 11
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 7
- Developments
- 4
- Repetition
- 43%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
C3.ai is expanding its AI solutions through partnerships with Microsoft and securing major wins with Bristol-Myers Squibb and USC Shoah Foundation.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.C3.ai secured AI wins with Bristol-Myers Squibb and formed distribution alliances with Microsoft.1 source
C3.ai expands partnerships with Microsoft, Amazon, and Baker Hughes, while facing market headwinds.1 source
C3.ai expands partnerships with Baker Hughes while navigating competitive pressure from Microsoft.1 source
C3.ai secures new enterprise clients, including Cargill and Shell, for its agentic AI solutions.1 source
Keep exploring
The entities involved
-
C3.ai
business
Nothing else this week.
-
Microsoft
American multinational technology corporation
- SpaceX listed shares on Nasdaq and reached a $2 trillion valuation, while the company explores ambitious plans like AI data centers in space and profitable Starlink operations.
- Major tech companies, including Meta, Microsoft, Amazon, OpenAI, and Oracle, are involved in an AI arms race that is influenced by Trump-era tariffs, with potential acquisitions mentioned regarding Siri.
-
Bristol-Myers Squibb
American pharmaceutical company
Related events
- Palantir Technologies, Salesforce, Microsoft, and Google are all ramping up their respective AI initiatives.
- Major tech firms announce partnerships and massive investments to accelerate AI adoption, cloud expansion, and data center infrastructure.
- Microsoft is developing the Maia 300 AI chip, which is being sought to power future exclusive AI infrastructure and secure $500B in funding.
- Microsoft is integrating PlantOS into its industrial AI ecosystem through a partnership with Infinite Uptime.
- Microsoft is paying OpenAI for AI models and building its own MAI system, while Nvidia maintains high margins in the competitive AI hardware market.
Coverage
Newest first; wire copies grouped- ZacksC3.ai's Generative AI Surge: A Catalyst for Fiscal 2026 Upside? C3.ai, Inc. AI closed fiscal 2025 with strong momentum, positioning its Generative AI and agentic AI platforms as central growth driver
- ZacksC3.ai Faces Hard Competition in Enterprise AI: Can It Defend the Turf? C3.ai, Inc. AI is capitalizing on the booming demand for enterprise AI. However, the company now faces a critical challenge. As
- BarchartCould This Once-Hot AI Stock Get Another Shot at Stardom? C3.ai Inc (AI) is winning back investors with a management shake-up that could redefine its future after CEO and founder Tom Siebel announced
- ZacksC3.ai's Agentic AI Push Scales Up: Can it Fuel a New Growth Cycle? C3.ai, Inc. AI is sharpening its focus on the emerging Agentic AI segment, a business line that is quickly evolving into a meaningfu
- Motley FoolThinking of Buying C3.ai Stock? Here Are 2 Red Flags to Consider. C3.ai is an important player in the enterprise AI industry. But the company is burning significant cash flow to grow. And competition
- Unknown outlet